David Felten - Creative Edge Chief Director
Director
Dr. David L. Felten, M.D., Ph. D. is Director of the Company. Dr. David L. Felten was recently Vice President, Research, and Medical Director of the Research Institute at Beaumont Health System, and the founding Associate Dean for research at the Oakland University William Beaumont School of Medicine. He oversaw the Health System research portfolio and actively participated in the development and commercialization of Beaumont intellectual property. He established a stateoftheart Core Molecular Laboratory and BioBank at Beaumont, strengthened the Beaumont Research Coordinating Center for oversight of multicenter clinical trials, and oversaw the conduct of all clinical translational research and basic research. Dr. Felten received a B.S. from the Massachusetts Institute of Technology in 1969, an M.D. from the University of Pennsylvania in 1973, and a Ph.D. in anatomyneurosciences through the Institute for Neurological Sciences at the University of Pennsylvania in 1974. He has received numerous honors and awards, including the John D. and Catherine T. MacArthur Foundation Prize Fellowship, and two separate 10year MERIT Awards from institutes at the National Institutes of Health. Previously, Dr. Felten was Dean of the School of Graduate Medical Education at Seton Hall University in South Orange, NJ, and was responsible for leadership of the residencies and fellowships in 5 large NJ hospitals, as well as graduate programs in allied health. He also served as Professor and then Chair of the Department of Neurobiology and Anatomy at the University of Rochester School of Medicine. Dr. Felten research documented direct connections between the nervous system and the immune system, and established the foundations for the field of brain, behavior, and immunity, and integrative medicine. since 2014.
| Tenure | 10 years |
| Address | 29235 Stephenson Highway, Madison Heights, MI, United States, 48071 |
| Phone | 313-655-1669 |
| Web | https://www.cenergynutrition.com |
Creative Edge Management Efficiency
The company has return on total asset (ROA) of (0.5141) % which means that it has lost $0.5141 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.571) %, meaning that it created substantial loss on money invested by shareholders. Creative Edge's management efficiency ratios could be used to measure how well Creative Edge manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Creative Edge's Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to rise to 3.57 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (1.26). At this time, Creative Edge's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 345.2 K in 2024, despite the fact that Net Tangible Assets are likely to grow to (10.2 M).Management Performance
| Return On Equity | -1.57 | ||||
| Return On Asset | -0.51 |
Creative Edge Nutrit Leadership Team
Elected by the shareholders, the Creative Edge's board of directors comprises two types of representatives: Creative Edge inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Creative. The board's role is to monitor Creative Edge's management team and ensure that shareholders' interests are well served. Creative Edge's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Creative Edge's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Thomas, VP | ||
| Paul Thomas, Co-Founder and Sr. VP | ||
| James Robinson, CEO and President and Director | ||
| David Felten, Chief Director | ||
| Joel Stohlman, Consultant Advisor | ||
| Dr MSM, Chief Research | ||
| Sam Alawieh, Chairman Officer | ||
| Keith Thomas, Chairman of the Board and Presidentident, CEO |
Creative Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Creative Edge a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.57 | ||||
| Return On Asset | -0.51 | ||||
| Profit Margin | (0.36) % | ||||
| Operating Margin | (0.35) % | ||||
| Current Valuation | 949.6 K | ||||
| Shares Outstanding | 4.75 B | ||||
| Price To Sales | 0.25 X | ||||
| Revenue | 92.28 K | ||||
| Gross Profit | 906.73 K | ||||
| EBITDA | (1.04 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Creative Stock Analysis
When running Creative Edge's price analysis, check to measure Creative Edge's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Edge is operating at the current time. Most of Creative Edge's value examination focuses on studying past and present price action to predict the probability of Creative Edge's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Edge's price. Additionally, you may evaluate how the addition of Creative Edge to your portfolios can decrease your overall portfolio volatility.